Mesothelioma - 56 Studies Found
| Completed |
: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma : Mesothelioma : 2006-11-20 :
|
| Completed |
: Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma : Mesothelioma : 2005-08-29 :
|
| Completed |
: Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays : Peritoneal Mesothelioma : 2016-04-27 : Genetic: comparative genomic analysis DNA and RNA extraction will be performed in Lyon University hospit |
| Completed |
: SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma : Mesothelioma : 2011-09-30 :
|
| Withdrawn |
: A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma : Malignant Pleural Mesothelioma : 2011-05-11 :
|
| Completed |
: Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) : Mesothelioma : 2010-09-15 : Drug: Zometa Zoledronic acid will be administered IV on the first day of a 21 day cycle at a concentrati |
| Active, not recruiting |
: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy :
|
| RECRUITING |
: MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI : Mesothelioma : 2024-12-04 : Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin. |
| RECRUITING |
: Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) : Mesotheliomas Pleural : 2024-12-04 : Pembrolizumab 200mg via IV infusion every 3 weeks for 2 cycles 3 pre-surgery, for 4 cycles post-surgery and then every 3 weeks during maintenance. |
| RECRUITING |
: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma : Malignant Peritoneal Mesothelioma : 2024-12-04 : Pemetrexed will be administered intravenously |